AI
Tuesday, June 07, 2016 12:55:29 PM
Valeant: Still the Sick Man of Pharmaceuticals
The clouds hanging over Valeant’s prospects just won’t go away. The drugmaker’s quarterly results have dashed any immediate hopes that its business is turning around.
VRX BIIB ALXN SRPT TRU NH LDRH NAV
The clouds hanging over Valeant’s prospects just won’t go away. The drugmaker’s quarterly results have dashed any immediate hopes that its business is turning around.
VRX BIIB ALXN SRPT TRU NH LDRH NAV
My post is for Your Eyes only and my entertainment
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
